How to Buy Urogen Pharma Stock
Urogen Pharma Ltd
UroGen Pharma Ltd. , a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases.
Urogen Pharma stock last closed at $12.03, up 8.57% from the previous day, and has decreased 31.26% in one year. It has overperformed other stocks in the Biotechnology industry by 0.45 percentage points. Urogen Pharma stock is currently +251.75% from its 52-week low of $3.42, and -36.72% from its 52-week high of $19.01.
As of Jun 13, 2025, there are 46.11M URGN shares outstanding. The market cap of URGN is $554.67M. In the last 24 hours, 19.69M URGN shares were traded.
How to Buy Urogen Pharma Stock
Not sure how to invest in Urogen Pharma stock? Here's how.
- Decide where to buy Urogen Pharma stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you determine where to buy Urogen Pharma stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your investment account: Pick your method of payment and add your info.
- Evaluate Urogen Pharma stock: The Urogen Pharma ticker symbol is URGN. Is Urogen Pharma stock a good investment? Should you buy shares of URGN? How do URGN's underlying business fundamentals look? Do top analysts think Urogen Pharma is a good buy? Why has URGN's stock price moved recently? (Hint: Our stock market research tools can help you decide if URGN is a good stock to buy).
- Make your URGN purchase: Decide if you will purchase URGN shares at the current market price or use a limit order to buy URGN stock at a specific price.
- Monitor your URGN investment: Create a watchlist to important notifications about your new investment in Urogen Pharma shares.
Step 1: Decide where to buy Urogen Pharma stock
You will need a brokerage account in order to access the NASDAQ market and buy URGN stock.
Our preferred brokerage: eToro
We believe that eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal information so you are able to invest in URGN stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to create a new trading account.
- Submit your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have created your account on our top ranked stock app, you need to deposit funds:
Watch the video below to see the process of depositing money into your new brokerage account.
Step 4: Evaluate Urogen Pharma stock
Once you have figured out the best place to buy Urogen Pharma stock, it's absolutely critical to evaluate their stock before you buy, so you actually wrap your head around the risk and upside.
Overview of key URGN info
Urogen Pharma Overview
WallStreetZen was built to help part-time investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on URGN's stock page.
How is URGN stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge URGN's fair value.
You can access more valuation research on URGN's stock here.
A look at URGN Cashflows and Balance Sheet
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the URGN balance sheet.
- URGN has $196.97M in cash and short term investments. This is sufficient to cover its annual cash burn of $107.39M.
- URGN has cash burn of 107394000. It has sufficient cash and short-term investments to cover this for at least one year.
Negative Health Checks:
- URGN debt to equity ratio of -6.33 is negative.
- There are more long-term liabilities than short-term assets on the URGN balance sheet.
- Total URGN debt is still negative.
- URGN profit margin has gone down from -123.7% to -150.7% in the past year.
Is it a good time to buy URGN stock, according to Wall Street analysts?
Out of 8 Equities analysts who track URGN, the consensus analyst rating on URGN is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
Latest URGN Analyst Forecasts
Paul Choi, a bottom 10% analyst from Goldman Sachs maintains URGN with a hold rating and lowers their URGN price target from $16.00 to $3.00, on May 22, 2025.
Raghuram Selvaraju, a top 4% analyst from HC Wainwright & Co. reiterates URGN with a buy rating and maintains their URGN price target from $55.00 to $55.00, on May 13, 2025.
An analyst from ScotiaBank initiates coverage on URGN with a buy rating and announces their URGN price target of $23.00, on Apr 16, 2025.
Aydin Huseynov, a bottom 2% analyst from Ladenburg Thalmann assumes URGN with a strong buy rating and announces their URGN price target of $31.00, on Feb 19, 2025.
You can dive deeper into what analysts are projecting on the Urogen Pharma stock forecast page.
Metrics for Advanced URGN Traders
URGN Performance Metrics
Last year, URGN revenue was $91.87M. Over the last 5 year, URGN's revenue has gone up by 451.55% per year. This was faster than the Biotechnology industry average of 43.24%.
You can research URGN's earnings and revenue performance here.
Who is buying/selling URGN?
Over the past 12 months, executives and large shareholders at URGN have sold more shares than they have bought.
Mark Schoenberg, Chief Medical Officer of URGN, was the latest URGN insider to sell. They sold $38,043.94 worth of URGN shares on Jun 9, 2025.
Dig into more about who owns URGN stock here.
Can I rely on URGN as an income stream?
No, Urogen Pharma doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your URGN purchase
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally the easiest way to buy. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact dollar amount, use a limit order.
Press the Open button and your broker will execute your order.
If you require additional help buying stocks on eToro, click the helpful video below:
Step 6: Monitor your URGN investment
Now that you own some URGN stock, you'll want to stay up-to-date on your investment.
Create a watchlist to track the latest developments regarding your URGN stock.
URGN Feed
How to Buy Stock in Urogen Pharma
To reiterate, here are the 6 steps to buy Urogen Pharma stock:
- Decide where to buy Urogen Pharma stock
- Create your brokerage account
- Fund your investment account
- Evaluate Urogen Pharma stock
- Make your URGN purchase
- Monitor your URGN investment
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Urogen Pharma, create a watchlist today.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.